Erik Schropp
Director/Board Member at POLYPEPTIDE GROUP AG
Net worth: 107 414 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michel Lucien Pettigrew | M | 71 |
SEVER Life Sciences BV
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | 23 years |
Jane Anne Salik | M | 71 |
PolyPeptide Laboratories Holding BV
PolyPeptide Laboratories Holding BV Financial ConglomeratesFinance Part of Draupnir Corp. NV, PolyPeptide Laboratories Holding BV is an investment holding Dutch company. The private company is based in Hoofddorp, Netherlands. | 21 years |
Patrick Aebischer | M | 70 | 3 years | |
Christina Del Vecchio | F | 46 | 3 years | |
Beat In-Albon | M | 72 | 3 years | |
Michael Stäheli | M | 59 | 3 years | |
Philippe Weber | M | 59 | 3 years | |
Neil James Thompson | M | 52 | 20 years | |
Olivier Ludemann-Hombourger | M | 52 | 12 years | |
Jon Holbech Rasmussen | M | 54 | 25 years | |
Monika Casanova | F | 45 | 2 years | |
Anne Thjømøe | F | - |
Svar Life Science AB
Svar Life Science AB Miscellaneous Commercial ServicesCommercial Services Svar Life Science AB is a Swedish company that provides GMP and non-GMP bioassay services for drug development. The private company is based in Malmö, Sweden. The company specializes in using activity biomarkers to determine if deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. The company offers method development, qualification, validation, and method improvements throughout the drug development lifecycle. Anne Thjømøe has been the CEO of the company since 2022. | 2 years |
Armin Metzger | M | - |
FinVector Oy
FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The private company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | 4 years |
Sean Davis | M | - |
SEVER Life Sciences BV
| - |
Juan-José Gonzalez | M | 52 | 1 years | |
Filiz Ibraimi | F | - |
Svar Life Science AB
Svar Life Science AB Miscellaneous Commercial ServicesCommercial Services Svar Life Science AB is a Swedish company that provides GMP and non-GMP bioassay services for drug development. The private company is based in Malmö, Sweden. The company specializes in using activity biomarkers to determine if deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. The company offers method development, qualification, validation, and method improvements throughout the drug development lifecycle. Anne Thjømøe has been the CEO of the company since 2022. | 3 years |
Jens Fricke | M | 59 | 2 years | |
Peter Wilden | M | 67 | 3 years | |
Marc Augustin | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Angelien G. Z. Kemna | M | 66 |
Erasmus University Rotterdam
| 6 years |
Bert L. L. Groenewegen | M | 60 |
Arthur Andersen Accountants
Arthur Andersen Accountants Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Arthur Andersen Accountants is a Dutch company that provides accounting services. The private company is based in Rotterdam, Netherlands. | 4 years |
Rolf Habben Jansen | M | 57 |
Erasmus University Rotterdam
| 4 years |
Helen Tveitan-de Jong | F | 56 |
Erasmus University Rotterdam
| 4 years |
Bart G. Enhus | M | 60 |
Erasmus University Rotterdam
| 6 years |
Mieke E. T. Pigeaud-Wijdeveld | F | 59 |
Erasmus University Rotterdam
| 4 years |
Harm van Maanen | M | 58 |
Erasmus University Rotterdam
| 4 years |
Dennis Okhuijsen | M | 53 |
Arthur Andersen Accountants
Arthur Andersen Accountants Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Arthur Andersen Accountants is a Dutch company that provides accounting services. The private company is based in Rotterdam, Netherlands. | 3 years |
Jan Miller | M | 54 | 8 years | |
Robert Swaak | M | 63 |
Erasmus University Rotterdam
| 1 years |
Antonius Berkien | M | 56 |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | 4 years |
Anthony Budiawan | M | 62 |
Erasmus University Rotterdam
| 1 years |
Sjoerd Mostert | M | - |
Erasmus University Rotterdam
| 5 years |
Dorothée Anna Deuring | F | 55 | 1 years | |
Gérard van Spaendonck | M | 53 |
Erasmus University Rotterdam
| 7 years |
Coen W. H. Vinke | M | 61 |
Erasmus University Rotterdam
| 2 years |
Rutger van Nouhuijs | M | 62 |
Erasmus University Rotterdam
| 1 years |
Daniel Lasanow | M | 62 | 6 years | |
Raymond de Vre | M | - | 2 years | |
Jan Christensen | M | 64 | 20 years | |
Leo Evers | M | 59 |
Erasmus University Rotterdam
| 2 years |
Jean Luc VanHulst | M | - |
Erasmus University Rotterdam
| 2 years |
H. R. G. Winter | M | 63 |
Erasmus University Rotterdam
| 4 years |
Hendrik-Jan Stoker | M | - |
Erasmus University Rotterdam
| 3 years |
Geert-Jan Schipper | M | 59 |
Erasmus University Rotterdam
| 4 years |
Marjan Johanna Oudeman | F | 65 |
Erasmus University Rotterdam
| 2 years |
Daan M. van Vlaardingen | M | - |
Erasmus University Rotterdam
| 6 years |
Renier Vree | M | 60 |
Erasmus University Rotterdam
| 4 years |
Pieter Nota | M | 60 |
Erasmus University Rotterdam
| 2 years |
Frank J. Tielens | M | 62 |
Erasmus University Rotterdam
| 1 years |
Paul Lageweg | M | 54 |
Erasmus University Rotterdam
| 6 years |
Lalit Ahluwalia | M | - | 1 years | |
Gijs F. J. van Thiel | M | 57 |
Erasmus University Rotterdam
| 3 years |
Marco Baptist Arie Keim | M | 62 |
Erasmus University Rotterdam
| 1 years |
Frans Putker | M | - |
Erasmus University Rotterdam
| 1 years |
Nicolaas Cornelis Jue | M | - |
Erasmus University Rotterdam
| 2 years |
Brent Wissink | M | 57 |
Erasmus University Rotterdam
| 4 years |
Martin Savelsbergh | M | - |
Erasmus University Rotterdam
| 3 years |
Rob Drijkoningen | M | - |
Erasmus University Rotterdam
| 6 years |
Peter Frank ter Kulve | M | 60 |
Erasmus University Rotterdam
| 4 years |
Peter Nordkild | M | 69 |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | - |
Rene M. Lipsch | M | - |
Erasmus University Rotterdam
| 6 years |
Richard Brinkman | M | - |
Arthur Andersen Accountants
Arthur Andersen Accountants Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Arthur Andersen Accountants is a Dutch company that provides accounting services. The private company is based in Rotterdam, Netherlands. | 5 years |
Floris van Woerkom | M | 61 |
Erasmus University Rotterdam
| 1 years |
Sikko A. J. van Katwijk | M | 61 |
Erasmus University Rotterdam
| 6 years |
Jurjan Wouda Kuipers | M | 61 |
Erasmus University Rotterdam
| - |
Statistics
Country | Connections | % of total |
---|---|---|
Netherlands | 41 | 63.08% |
Switzerland | 20 | 30.77% |
Denmark | 3 | 4.62% |
Sweden | 2 | 3.08% |
Finland | 1 | 1.54% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Erik Schropp
- Personal Network